Creating Monoclonal Antibodies for Breast Cancer Detection
Author Information
Author(s): V. Apostolopoulos, P.-X. Xing, J.A. Trapani, I.F.C. McKenzie
Primary Institution: The Austin Research Institute, Austin Hospital
Hypothesis
Can a bacterial fusion protein be used to produce monoclonal antibodies that specifically target breast cancer?
Conclusion
The study successfully produced two monoclonal antibodies that can detect breast cancer with varying specificity.
Supporting Evidence
- VA1 detected 46 out of 53 breast cancers.
- VA2 detected 48 out of 53 breast cancers.
- VA1 showed weak reactions with normal breast tissues.
- VA2 was non-reactive with formalin fixed normal breast tissues.
Takeaway
Scientists made special proteins that help find breast cancer cells, and they found two that work really well.
Methodology
Monoclonal antibodies were produced using a bacterial fusion protein and tested on various cancer and normal tissues.
Limitations
The antibodies reacted with some normal tissues, indicating they are not entirely specific to breast cancer.
Want to read the original?
Access the complete publication on the publisher's website